Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wart treatment with anthralin.

H Flindt-Hansen, G Tikjøb, F Brandrup

    Acta Dermato-Venereologica
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Anthralin (Anthraderm) effectively treats warts, showing a 56% cure rate in a randomized trial. This topical treatment demonstrated superior efficacy compared to Verucid, particularly for hand warts.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Identification of two new mutations in the TAT gene in a Danish family with tyrosinaemia type II.

    The British journal of dermatology·2008
    Same author

    A founder mutation for ichthyosis prematurity syndrome restricted to 76 kb by haplotype association.

    Journal of human genetics·2006
    Same author

    Skin manifestations in a case of trisomy 16 mosaicism.

    The British journal of dermatology·2006
    Same author

    A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2005
    Same author

    Pigmentary mosaicism with mosaic chromosome 5p tetrasomy.

    The British journal of dermatology·2003
    Same author

    Raman spectroscopy analysis of protein structure of hair in patients with trichothiodystrophy.

    The British journal of dermatology·2003
    Same journal

    A Facial Lesion with Cord-like Induration and Ring-like Appearance on MRI: A Quiz.

    Acta dermato-venereologica·2026
    Same journal

    Real-world Outcomes of Adalimumab in Hidradenitis Suppurativa: A 10-year Retrospective Longitudinal Study.

    Acta dermato-venereologica·2026
    Same journal

    An 8-year-old Girl with Multiple Whitish Dots on the Hair Shaft: A Quiz.

    Acta dermato-venereologica·2026
    Same journal

    A Congenital Subcutaneous Tumour of the Scalp in a Child: A Quiz.

    Acta dermato-venereologica·2026
    Same journal

    Commentary on: "The Effects of Sun Exposure and Pigmentation Phenotype on Prognosis in Metastatic Melanoma".

    Acta dermato-venereologica·2026
    Same journal

    Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study.

    Acta dermato-venereologica·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Clinical Research
    • Pharmacology

    Background:

    • Warts are common skin infections caused by human papillomavirus (HPV).
    • Existing treatments for warts have varying efficacy and side effect profiles.
    • Anthralin is a topical agent with potential therapeutic applications.

    Purpose of the Study:

    • To evaluate the efficacy of anthralin (Anthraderm) in treating warts.
    • To compare the effectiveness of anthralin with a comparative drug, Verucid.
    • To identify patient subgroups that may benefit most from anthralin treatment.

    Main Methods:

    • A randomized controlled trial was conducted with 72 patients.
    • Participants were treated with either 2% anthralin (Anthraderm) or Verucid for two months.

    Related Experiment Videos

  • Efficacy was assessed at follow-up, 2-9 months post-treatment.

    • Main Results:

    • A 56% cure rate was observed in the anthralin group, compared to 26% in the Verucid group.
    • Anthralin 2% (Anthraderm) showed significantly better treatment outcomes.
    • The efficacy of anthralin was particularly pronounced in patients with warts exclusively on their hands.

    Conclusions:

    • Anthralin 2% (Anthraderm) is an effective treatment for warts.
    • Anthralin demonstrates superior efficacy over Verucid for wart removal.
    • Hand warts represent a specific indication where anthralin shows enhanced effectiveness.